Early Online
Open Access DOI:10.23937/2469-570X/1410080
Ravjot Kaur Virdi, DO, MPH and Jacob D. Bitran, MD
Article Type: ORIGINAL ARTICLE | First Published: May 05, 2025
Many hematologic malignancies, including leukemia (AML/CML), myelodysplastic syndrome (MDS), and aplastic anemia, predominantly affect older adults. Allogeneic hematopoietic stem cell transplantation (AHSCT) offers a potential cure for intermediate- to high-risk disease. However, it is infrequently offered to patients older than 70 due to concerns about tolerability. AHSCT in elderly patients remains a challenge. Further studies are needed to refine patient selection criteria, identify key demog...
Article Formats
- Full Article
- XML
- EPub Reader

Volume 11
Issue 1
Issue 1